Treating Multiple Mylomas Through Autologous Stem Cell Transplant

Autologous Stem Cell Transplant in India

There is a new line of treatment for treating the multiple myelomas in patients. Earlier bone marrow transplant was used to treat multiple myelomas which has been replaced by autologous stem cell transplant. An autologous stem cell transplant uses a very high intensity chemotherapy which kills the myeloma cells and also the the healthy normal blood forming cells known as hematopoeitic stem cells. In order to replace these healthy hematopoeitic stem cells, an autologous stem cell transplant  is used. These healthy hematopoeitic stem cells can be found in the bone marrow and in the peripheral blood such as veins and arteries.

Before the treatment starts there are various parameters on which the line of treatment for Autologous Stem Cell Transplant is decided. These factors may include patients age, genetic profile, body type, lifestyle, expectations etc. Once these details have been studied then the line of treatment is prescribed.

In Autologous Stem Cell Transplant before the treatment starts the stem cells are preserved. Post the radiotherapy  which involves chemotherapy, these stem cells are reintroduced/infused into the patients blood system. An Autologous Stem Cell Transplant is a very common type of transplant which is done in case of myeloma patients. Also such transplants have lesser complications than transplants which require a donor.

The cost of getting Autologous Stem Cell Transplant for multiple myelomas is approximately $20,000 USD. Patients have to stay in hospital for two weeks or 14 days in total. Post hospital stay another 14 days of stay is required in India for the Autologous Stem Cell Transplant to be completely done.

India is having some very advanced stem cell transplant centres that are offering treatments for various diseases. In the last few years stem cell transplant has become a popular choice amongst the patients. Not only is the cost of stem cell transplant in India highly affordable but also India is one of the leading research destination for stem cell research programs.